Australia's most trusted
source of pharma news
Friday, 14 February 2025
Posted 15 May 2024 PM
After almost 14 years at Pfizer Emma Bonser has landed a new role as CEO at Genetic Alliance Australia.
Bonser finished up at Pfizer in January after three years as Gene Therapy Business Lead, Rare Disease ANZ and South Korea. She started at the company in 2010 - spent a year in Cambodia working for an NGO between 2016 and 2016 - before returning to Pfizer and specialising in rare disease.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.